Atrial Fibrillation Trial To Eliminate Risk-factors

Recruiting

• Conditions: Atrial Fibrillation

• Registration Number: NCT05718336
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

The goal of this prospective-enrolling cohort study is to test and observe the effect of an integrated multi-discipline care program in patients with atrial fibrillation. The main questions it aims to answer are:

1. to understand the baseline characteristics and to explore the occult risk factors of the patients with AF;

2. to monitor the treatment efficacy of the patients undergoing integrated care and potentially concur the clinical obstacles that prevent the best care for patients with AF.

Participants will be treated by an integrated multi-discipline team that led by an electro-physiologist.

Detailed Description

Atrial fibrillation (AF) is a heart condition that potentially leads to heart failure and ischemic stroke. The prevalence of AF is increasing due to aging population and improved treatment in other cardiovascular field. This study is to execute integrated multi-discipline care in a tertiary hospital, and to observe the effect and the obstacle that the program might ensue.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2020-05-01
• Status Verified: 2023-01
• Study First Submitted: 2023-01-30
• Study First Submitted QC: 2023-01-30
• Last Update Submitted: 2023-01-30
• Study First Posted: 2023-02-08
• Last Update Posted: 2023-02-08
• Primary Completion: 2024-12-31
• Study Completion: 2024-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• At least 20 years old, who have been diagnosed with atrial fibrillation by a cardiologist with an electrocardiogram

Read More

Exclusion Criteria

1. Unable to complete the initial assessment and cooperate with the tracker
2. Those who refuse to sign the subject's consent

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
AF burden	0~24 months	The duration in AF on 14-day ECG monitor (percent)

Secondary Outcome Measures

Name	Time	Method
MACE, major adverse cardiovascular event	0~24 months	ischemic heart disease with acute coronary syndrome, stroke (either ischemic or hemorrhagic stroke), cardiovascular death, and all-cause death

Trial Locations

Locations (1)

National Taiwan University Hospita; 🇨🇳 Taipei,, Taiwan